Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test

Neuroscience Letters

Volumn 390, Issue 2, 2005, Pages 114-117

  Yoon, Myung Ha ^a   Jeong, Il Choi ^a   Hong, Beom Bae ^a   Seong, Wook Jeong ^a   Sung, Su Chung ^a   Kyung, Yeon Yoo ^a   Chang, Young Jeong ^a   Seok, Jae Kim ^a   Sung, Tae Chung ^a   Chang, Mo Kim ^a  

^a Chonnam National University   (South Korea)

Author keywords

Antinociception; Formalin test; Nitric oxide cGMP potassium channel pathway; Spinal cord; Sprague Dawley rat; Zaprinast

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; FORMALDEHYDE; GLIBENCLAMIDE; N(G) METHYLARGININE; NITRIC OXIDE; POTASSIUM; POTASSIUM CHANNEL; ZAPRINAST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EPIDURAL CATHETER; EPIDURAL SPACE; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; RAT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANALGESICS; ANIMALS; CYCLIC GMP; FORMALDEHYDE; GLYBURIDE; INJECTIONS, SPINAL; MALE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXADIAZOLES; PAIN; PAIN MEASUREMENT; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHANNELS; PURINONES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 26244440277     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.08.006     Document Type: Article

References (25)

1. L.H. Amarante, and I.D. Duarte The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway Eur. J. Pharmacol. 454 2002 19 23
2. R. Asomoza-Espinosa, R. Alonso-Lopez, T. Mixcoatl-Zecuatl, P. Aguirre-Banuelos, J.E. Torres-Lopez, and V. Granados-Soto Sildenafil increases diclofenac antinociception in the formalin test Eur. J. Pharmacol. 418 2001 195 200
3. J.A. Beavo Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms Physiol. Rev. 75 1995 725 748
4. J.A. Beavo, and D.H. Reifsnyder Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors Trends Pharmacol. Sci. 11 1990 150 155
5. F.Q. Cunha, M.M. Teixeira, and S.H. Ferreira Pharmacological modulation of secondary mediator systems - cyclic AMP and cyclic GMP - on inflammatory hyperalgesia Br. J. Pharmacol. 127 1999 671 678
6. T. Deguchi Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain J. Biol. Chem. 252 1977 7617 7619
7. I.D. Durate, B.B. Lorenzetti, and S.H. Ferreira Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway Eur. J. Pharmacol. 186 1990 289 293
8. S.H. Ferreira, I.D. Duarte, and B.B. Lorenzetti The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release Eur. J. Pharmacol. 201 1991 121 122
9. 2+ dependent process Prostaglandins 18 1979 179 190
10. V. Granados-Soto, M.O. Rufino, L.D. Gomes Lopes, and S.H. Ferreira Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test Eur. J. Pharmacol. 340 1997 177 180
11. M. Islas-Cadena, P. Aguirre-Banuelos, and V. Granados-Soto Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide J. Pharmacol. Toxicol. Methods 42 1999 87 92
12. N.K. Jain, C.S. Patil, A. Singh, and S.K. Kulkarni Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway Brain Res. 909 2001 170 178
13. N.K. Jain, C.S. Patil, A. Singh, and S.K. Kulkarni Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine Pharmacology 67 2003 150 156
14. G.G. Lazaro-Ibanez, J.E. Torres-Lopez, and V. Granados-Soto Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac Eur. J. Pharmacol. 426 2001 39 44
15. T. Mixcoatl-Zecuatl, P. Aguirre-Banuelos, and V. Granados-Soto Sildenafil produces antinociception and increases morphine antinociception in the formalin test Eur. J. Pharmacol. 400 2000 81 87
16. R.B. Moreland, I.I. Goldstein, N.N. Kim, and A. Traish Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor Trends Endocrinol. Metab. 10 1999 97 104
17. M.I. Ortiz, V. Granados-Soto, and G. Castaneda-Hernandez The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin Pharmacol. Biochem. Behav. 76 2003 187 195
18. M.I. Ortiz, J.E. Torres-Lopez, G. Castaneda-Hernandez, R. Rosas, G.C. Vidal-Cantu, and V. Granados-Soto Pharmacological evidence for the activation of K(+) channels by diclofenac Eur. J. Pharmacol. 438 2002 85 91
19. C.S. Patil, N.K. Jain, A. Singh, and S.K. Kulkarni Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception Pharmacology 69 2003 183 189
20. N.J. Pyne, V. Arshavsky, and A. Lochhead cGMP signal termination Biochem. Soc. Trans. 24 1996 1019 1022
21. A.R. Rodrigues, and I.D. Duarte The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels Br. J. Pharmacol. 129 2000 110 114
22. A.C. Soares, R. Leite, M.A. Tatsuo, and I.D. Duarte Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside Eur. J. Pharmacol. 400 2000 67 71
23. A.M. Sousa, and W.A. Prado The dual effect of a nitric oxide donor in nociception Brain Res. 897 2001 9 19
24. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol. Behav. 17 1976 1031 1036
25. I. Yamazumi, T. Okuda, and Y. Koga Involvement of potassium channels in spinal antinociceptions induced by fentanyl, clonidine and bethanechol in rats Jpn. J. Pharmacol. 87 2001 268 276